Comment concerning: Intraoperative 5-aminolevulinic-acid-induced fluorescence in meningiomas, Acta Neurochir DOI 1O.1007/s00701-010-0708-4, Intratumoral heterogeneity and fluorescence intensity in meningioma after 5-ALA pretreatment

Acta Neurochirurgica

Volumn 153, Issue 4, 2011, Pages 959-960

  Hefti, Martin ^a,b  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b Hospital Group Hirslanden   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID;

BRAIN SURGERY; CANCER GRADING; CANCER INFILTRATION; CANCER SURGERY; CANCER SURVIVAL; CELL LEVEL; CELL TYPE; CELLULAR DISTRIBUTION; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; DIAGNOSTIC VALUE; FLUORESCENCE ANALYSIS; FLUORESCENCE IMAGING; GENETIC HETEROGENEITY; GLIOMA; HUMAN; INTRAOPERATIVE PERIOD; LETTER; MENINGIOMA; NEUROPATHOLOGY; PEROPERATIVE CARE; PRIORITY JOURNAL; PROGNOSIS; SURGICAL ANATOMY; TUMOR LOCALIZATION; TUMOR NECROSIS; TUMOR RECURRENCE;

AMINOLEVULINIC ACID; CHROMOSOME ABERRATIONS; FLUORESCENCE; GENETIC HETEROGENEITY; HUMANS; INTRAOPERATIVE PERIOD; MENINGEAL NEOPLASMS; MENINGIOMA; NECROSIS; NEOPLASM INVASIVENESS; PHOTOSENSITIZING AGENTS; PREMEDICATION; PROGNOSIS;

EID: 79955846111     PISSN: 00016268     EISSN: 09420940     Source Type: Journal    
DOI: 10.1007/s00701-011-0950-4     Document Type: Letter

References (10)

1. Hashemi M, Schick U, Hassler W, Hefti M (2010) Tentorial meningiomas with special aspect to the tentorial fold: management, surgical technique, and outcome. Acta Neurochir Wien 152 (5):827-834
2. Hefti M, Holenstein F, Albert I, Looser H, Luginbuehl V (2010) Susceptibility to 5-aminolevulinic acid based photodynamic therapy in WHO I meningioma cells corresponds to ferrochelatase activity. Photochemistry and Photobiology doi:10.1111/j.1751-1097.2010.00821
3. Hefti M, von Campe G, Moschopulos M, Siegner A, Looser H, Landolt H (2008) 5-aminolaevulinic acid-induced protoporphyrin IX fluorescence in high-grade glioma surgery. Swiss Med Wkly 138(11-12):180-185 (Pubitemid 351480812)
4. Pfisterer WK, Hank NC, Preul MC, Hendricks WP, Pueschel J, Coons SW, Scheck AC (2004) Diagnostic and prognostic significance of gentetic regional heterogeneity in meningiomas. Neuro Oncol Oct 6(4):290-9 (Pubitemid 39429832)
5. Philippon J, Cornu P (1991) The recurrence of meningiomas. In: Al-Mefty O (ed) Meningiomas. Raven Press, New York, pp 87-106
6. Sayagues JM, Tabernero MD, Maillo A, Espinosa A, Rasillo A, Diaz P, Ciudad J, Lopez A, Merino M, Goncalves JM, Santos-Briz A, Morales F, Orfao A (2004) Intratumoral pattern of clonal evolution in meningiomas as defined by multicolour interphase fluorescence in situ hypridization (FISH): is there a relationship between histopathologically benign and atypical/anaplastic lesions? J Mol Diagn Nov 6(4):316-25
7. Scheck AC, Shapiro JR, Coons SW, Norman SA, Johnson PC (1996) Biological and molecular analysis of a low grade recurrence of a glioblastoma multiforme. Clin Cancer Res 2:187-199 (Pubitemid 26042192)
8. Scholz M, Gottschalk J, Striepecke E, Firsching R, Harders A, Fuzesi L (1996) Intratumorous heterogeneity of chromosome 10 and 17 in meningiomas using non-radioactive in situ hybridization. J Neurosurg Sci 40:17-23 (Pubitemid 26352786)
9. Simpson D (1957) The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatr 20(1):22-39
10. Yoshinaga K, Toshihiko K, Shin-Iichi M, Tsugumichi I, Minoru M, Hidekazu T, Motomu T (2007) Use of 5-aminolevulinic acid in fluorescence-guided resection of meningioma with high risk of recurrence. J Neurosurg 106:1070-1074